How can we overcome ibrutinib resistance?
T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Achieving deep responses in previously treated CLL patients
What are the best molecular diagnostic techniques in CLL?